Auxly Cannabis Group Inc (TSE:XLY)
TSX:XLY
Want to see TSE:XLY full AI Analyst Report?
XLY Stock Chart & Stats
C$0.14
>-C$0.01(-10.00%)
At close: 4:00 PM EST
C$0.14
>-C$0.01(-10.00%)
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.19
Previous CloseN/A
Volume80.76K
Average Volume (3M)979.68K
Market Cap
C$217.49M
Enterprise ValueC$223.34M
Total Cash (Recent Filing)C$43.06M
Total Debt (Recent Filing)C$55.78M
Price to Earnings (P/E)6.2
Beta1.03
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding1,403,150,400
10 Day Avg. Volume1,296,089
30 Day Avg. Volume979,678
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.25Price Target Upside78.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$162.60M
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Profitability RecoveryAuxly's multi-year revenue improvement to $158.6M TTM and return to operating and net profitability signal a structural recovery. Sustained revenue momentum combined with positive earnings supports durable cash generation, reinvestment capacity and stronger stakeholder confidence over 2–6 months.
Material Improvement In Cash GenerationA clear shift to positive operating and free cash flow indicates the business now converts sales into liquidity. This sustained cash generation enhances financial flexibility, funds working capital and capital expenditures, and reduces refinancing reliance across the medium term.
Stronger Balance Sheet And Lower LeverageSignificantly reduced leverage and higher equity restore resilience to the capital structure. Improved balance sheet reduces refinancing risk, supports investment in scale and product development, and makes the company better positioned to absorb regulatory or demand shocks.
Bears Say
Recent Margin CompressionMargin erosion in the most recent TTM versus 2025 suggests pressure on product mix, pricing or cost absorption. If sustained, this reduces cash flow margins and limits reinvestment, making earnings more sensitive to volume swings and competitive pricing over the medium term.
Short Track Record Of Cash StrengthWhile cash generation is now positive, it follows a period of negative cash flow, indicating the improvement is recent. This shorter track record raises execution risk: a downturn or slower demand could reverse cash gains before the company builds a multi-cycle history of consistent conversion.
Dependence On Regulated Provincial ChannelsAuxly's revenue heavily depends on provincial listings, regulatory approvals and distributor relationships. This concentration exposes the business to regulatory shifts, provincial procurement changes and listing losses that can materially affect shelf presence and long-term sales stability.
Auxly Cannabis Group News
XLY FAQ
What was Auxly Cannabis Group Inc’s price range in the past 12 months?
Auxly Cannabis Group Inc lowest stock price was C$0.07 and its highest was C$0.19 in the past 12 months.
What is Auxly Cannabis Group Inc’s market cap?
Auxly Cannabis Group Inc’s market cap is C$217.49M.
When is Auxly Cannabis Group Inc’s upcoming earnings report date?
Auxly Cannabis Group Inc’s upcoming earnings report date is Aug 17, 2026 which is in 74 days.
How were Auxly Cannabis Group Inc’s earnings last quarter?
Auxly Cannabis Group Inc released its earnings results on May 14, 2026. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is Auxly Cannabis Group Inc overvalued?
According to Wall Street analysts Auxly Cannabis Group Inc’s price is currently Undervalued.
Does Auxly Cannabis Group Inc pay dividends?
Auxly Cannabis Group Inc does not currently pay dividends.
What is Auxly Cannabis Group Inc’s EPS estimate?
Auxly Cannabis Group Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Auxly Cannabis Group Inc have?
Auxly Cannabis Group Inc has 1,403,150,400 shares outstanding.
What happened to Auxly Cannabis Group Inc’s price movement after its last earnings report?
Auxly Cannabis Group Inc reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of Auxly Cannabis Group Inc?
Currently, no hedge funds are holding shares in TSE:XLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Auxly Cannabis Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$0.25 (78.57% Upside)
C$0.25 (78.57% Upside)
Insider Transactions
Bought Shares
Worth C$100.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
300.00%
12-Months-Change
Fundamentals
Return on Equity
19.79%
Trailing 12-Months
Asset Growth
8.92%
Trailing 12-Months
Company Description
Auxly Cannabis Group Inc
Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. The company focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. It offers cannabis products under various forms, including vape catridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy under the brands KOLAB PROJECT, Dosecann, BACK FORTY, and Foray. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada.
XLY Earnings Call
Q1 2026
0:00 / 0:00
XLY Stock 12 Month Forecast
Average Price Target
C$0.25
▲(78.57% Upside)
Technical Analysis
Canopy Growth
―
Organigram Global
―
Aurora Cannabis
―
Cronos Group
―
Trulieve Cannabis
―
Options Prices
Currently, No data available
---